KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Interest Expenses (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Interest Expenses for 8 consecutive years, with $24000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 73.91% to $24000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86000.0 through Dec 2025, down 83.49% year-over-year, with the annual reading at $86000.0 for FY2025, 85.1% down from the prior year.
  • Interest Expenses hit $24000.0 in Q4 2025 for Castle Biosciences, roughly flat from $24000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $216000.0 in Q2 2024 to a low of $1000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $37411.8 across 5 years, with a median of $6000.0 in 2022.
  • Biggest five-year swings in Interest Expenses: plummeted 99.75% in 2021 and later skyrocketed 9950.0% in 2024.
  • Year by year, Interest Expenses stood at $1000.0 in 2021, then skyrocketed by 300.0% to $4000.0 in 2022, then plummeted by 50.0% to $2000.0 in 2023, then skyrocketed by 4500.0% to $92000.0 in 2024, then plummeted by 73.91% to $24000.0 in 2025.
  • Business Quant data shows Interest Expenses for CSTL at $24000.0 in Q4 2025, $24000.0 in Q3 2025, and $21000.0 in Q2 2025.